Comparative Investigation of Human Amniotic Epithelial Cells and Mesenchymal Stem Cells for Application in Bone Tissue Engineering

Table 1

Comparison of cells immunophenotype profiles.

	Basic surface markers panel				Immunologic surface markers panel
	hAFMSCs (% Pos)	hAECs (% Pos)	hBMSCs (% Pos)		hAFMSCs (% Pos)		hAECs (% Pos)		hBMSCs (% Pos)
					IFN-γ (−)	IFN-γ (+)	IFN-γ (−)	IFN-γ (+)	IFN-γ (−)	IFN-γ (+)
CD105	58.10 ± 7.15	45.27 ± 6.27	95.37 ± 4.90	HLA-ABC	99.46 ± 0.39	99.80 ± 0.17	99.53 ± 0.31	99.53 ± 0.31	97.17 ± 1.06	97.61 ± 1.47
CD90	91.67 ± 4.50	83.53 ± 12.24	91.60 ± 3.50	HLA-DR	0.59 ± 0.26	54.82 ± 1.83	0.56 ± 0.17	0.68 ± 0.29	3.37 ± 1.36	94.47 ± 8.80
CD44	86.87 ± 4.90	32.27 ± 8.05	88.70 ± 6.35	HLA-G	0.79 ± 0.51	1.16 ± 0.50	2.27 ± 1.09	11.66 ± 11.03	1.17 ± 0.43	1.29 ± 0.75
CD34	0.06 ± 0.07	0.14 ± 0.18	0.13 ± 0.07	HLA-E	1.26 ± 0.14	62.78 ± 19.07	1.93 ± 0.79	97.63 ± 1.50	2.10 ± 0.71	33.83 ± 10.18
CD45	0.09 ± 0.09	0.16 ± 0.25	0.22 ± 0.15	PD-L1	88.51 ± 4.82	99.47 ± 0.59	98.93 ± 0.91	99.70 ± 0.26	9.85 ± 5.61	98.80 ± 0.62
SSEA4	8.10 ± 4.84	52.47 ± 11.82	0.04 ± 0.04	PD-L2	34.26 ± 14.01	64.72 ± 14.63	27.63 ± 15.48	59.10 ± 27.55	10.37 ± 4.54	23.57 ± 14.69
SSEA3	14.73 ± 8.00	46.87 ± 4.30	1.38 ± 0.82	TLR5	1.00 ± 0.32	3.48 ± 2.27	0.43 ± 0.22	0.67 ± 0.20	0.63 ± 0.04	1.52 ± 1.57
				TLR6	0.55 ± 0.25	0.64 ± 0.07	0.55 ± 0.16	0.56 ± 0.16	0.58 ± 0.13	0.70 ± 0.16
				FasL	0.48 ± 0.22	0.79 ± 0.13	0.75 ± 0.55	0.62 ± 0.14	0.58 ± 0.19	0.82 ± 0.11
				Fas	58.98 ± 4.33	97.04 ± 0.89	21.10 ± 7.93	40.43 ± 7.98	11.15 ± 4.38	22.78 ± 7.30